Healthcare Resource Utilization and Treatment Costs for Blastic Plasmacytoid Dendritic Cell Neoplasm: A PETHEMA Study
The active treatment of BPDCN imposes a high economic burden and extensive HCRU. Comparative pharmacoeconomic studies evaluating the cost-effectiveness of new therapies for BPDCN are needed to identify patient subgroups that may benefit most from these treatments.
Authors
- Pau Montesinos (ORCID: https://orcid.org/0000-0002-3275-5593)
- Rebeca Rodríguez‐Veiga (ORCID: https://orcid.org/0000-0003-2139-8540)
- David Martínez‐Cuadrón (ORCID: https://orcid.org/0000-0001-7540-4091)
- Laura Torres-Miñana (ORCID: https://orcid.org/0009-0005-6930-8059)
- Lorenzo Algarra (ORCID: https://orcid.org/0000-0002-2527-824X)
- C Olivier (ORCID: https://orcid.org/0000-0001-9739-5747)
- Sara Sánchez-Sánchez
- Isabel Cano‐Ferri
- Armando V. Mena-Durán (ORCID: https://orcid.org/0000-0001-5141-0382)
- Josefina Serrano (ORCID: https://orcid.org/0000-0003-1608-6016)
- Pilar Lloret Madrid (ORCID: https://orcid.org/0009-0003-6661-9631)
- Raimundo García‐Boyero (ORCID: https://orcid.org/0000-0001-9473-1004)
- Eduardo Rodríguez‐Arbolí (ORCID: https://orcid.org/0000-0002-2237-6733)
- Evelyn Acuña‐Cruz (ORCID: https://orcid.org/0000-0003-2869-369X)
- María Centelles-Oria (ORCID: https://orcid.org/0000-0003-2902-6178)
- Juan Bergua (ORCID: https://orcid.org/0000-0001-8229-1208)
- Víctor Noriega (ORCID: https://orcid.org/0000-0001-8931-5567)
- Teresa Bernal (ORCID: https://orcid.org/0000-0002-2338-513X)
- Blanca Boluda (ORCID: https://orcid.org/0000-0002-1785-5561)
- Antonio Solana‐Altabella (ORCID: https://orcid.org/0000-0002-8804-3878)
- Eduardo López Briz (ORCID: https://orcid.org/0000-0002-6519-522X)
- Irene Navarro-Vicente
- José Luís Poveda (ORCID: https://orcid.org/0000-0003-1800-6198)
- Mario Rodenas-Rovira (ORCID: https://orcid.org/0000-0003-2256-3595)
- Jackeline Solano-Tovar
- Carmen Botella-Prieto (ORCID: https://orcid.org/0000-0002-3500-4146)
- Vicente Carrasco-Baraja
Institutions
- Hospital Universitari i Politècnic La Fe (ES)
- Hospital General De Segovia (ES)
- Instituto Maimónides de Investigación Biomédica de Córdoba (ES)
- Hospital Royo Villanova (ES)
- Hospital San Pedro de Alcántara (ES)
- Hospital General Universitari de Castelló (ES)
- Hospital General Universitario De Valencia (ES)
- Instituto de Biomedicina de Sevilla (ES)
- Hospital Universitario Central de Asturias (ES)
- Hospital General Universitario de Alicante Doctor Balmis (ES)
- Complexo Hospitalario Universitario A Coruña (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Complejo Hospitalario Universitario de Albacete (ES)
- Hospital Marina Baixa (ES)
- Complejo Asistencial Universitario de Palencia (ES)
- Instituto de Investigación Sanitaria La Fe (ES)
- Universidad de Sevilla (ES)
Publication Details
- Journal
- Cancers
- Published
- 2025-08-29
- DOI
- https://doi.org/10.3390/cancers17172844
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Menarini Group
- Instituto de Salud Carlos III